[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$crdf

Cardiff Oncology ($CRDF) receives a buy rating from Ladenburg Thalmann with a $XX target. Traders are seeing gains, but there are concerns about drug trial outcomes.

About $crdf

Cardiff Oncology ($CRDF) is a biotechnology company focused on developing and commercializing novel therapies for the treatment of cancer.

Engagements: XXXXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXX
1 Month: XXXXXXX +166%
1-Year High: XXXXXX on 2025-07-10
1-Year Low: XXX on 2025-06-07

Social Network	X
Engagements	XXXXX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XXX -XX%
1 Month: XXXXX +2,871%
1-Year High: XXXXX on 2025-07-10
1-Year Low: X on 2025-04-27

Social Network	X
Mentions	XX

Creators: XX #

Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning $crdf in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
1 Week: XX -XX%
1 Month: XXXXX +2,417%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-04-27

The most influential creators that mention $crdf in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@jeremyj0916	X	XXX	X	XXX

Sentiment: XXX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XXX%
1 Month: XXX% no change
1-Year High: XXX% on 2025-04-28
1-Year Low: XX% on 2025-07-08

Most Supportive Themes

Positive FDA Approval: (40%) Positive sentiment around potential FDA approval and the drug's role in treating colorectal cancer.
General Bullish Sentiment: (30%) Mentions of $CRDF alongside other stocks with positive performance, suggesting a general bullish sentiment.
Successful Trading Strategies: (20%) Mentions of $CRDF in the context of successful trading strategies and gains.

Most Critical Themes

Drug Trial Uncertainty: (10%) Concerns about potential delays or negative outcomes related to the drug Onvansertib.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXX	XX%	XXXXX	XX%	X	X%

Total	XXX	XX%	XXXXX	XX%	X	X%

Top assets mentioned In the posts about $crdf in the last XX hours

Amazon.com, Inc. (AMZN) SPX6900 (SPX) NVIDIA Corp. (NVDA) Apple, Inc. (AAPL) Tesla, Inc. (TSLA) Tesla, Inc. (TSLA) Bitdeer Technologies Group (BTDR) Bitdeer Technologies Group (BTDR) Regencell Bioscience Holdings Limited Ordinary Shares (RGC) Scholar Rock Holding Corporation Common Stock (SRRK)

Top topics mentioned In the posts about $crdf in the last XX hours